Holen Sie sich die Stockscreener-App
13.75
0.79%
-0.11
Schlusskurs vom Vortag:
$13.86
Offen:
$13.85
24-Stunden-Volumen:
143.09K
Relative Volume:
0.80
Marktkapitalisierung:
$520.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.78M
KGV:
-5.1306
EPS:
-2.68
Netto-Cashflow:
$-53.91M
1W Leistung:
+0.95%
1M Leistung:
+16.72%
6M Leistung:
+25.80%
1J Leistung:
-24.33%
1-Tages-Spanne:
$13.70
$14.45
1-Wochen-Bereich:
$13.35
$14.50
52-Wochen-Spanne:
$7.575
$19.77
Celcuity Inc Stock (CELC) Company Profile
Firmenname
Celcuity Inc
Sektor
Branche
Telefon
763-392-0767
Adresse
16305 36TH AVENUE N, MINNEAPOLIS, MN
Vergleichen Sie CELC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
13.75 | 515.74M | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Fortgesetzt | Stifel | Buy |
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-22 | Eingeleitet | Stifel | Buy |
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-07 | Eingeleitet | Jefferies | Buy |
| 2021-07-29 | Eingeleitet | Cowen | Outperform |
| 2021-07-27 | Eingeleitet | Needham | Buy |
| 2021-01-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-11 | Fortgesetzt | Craig Hallum | Buy |
| 2018-11-20 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Celcuity Inc Aktie (CELC) Neueste Nachrichten
What analysts say about Celcuity Inc. stockConsistently profitable trades - Jammu Links News
Celcuity Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Jammu Links News
What makes Celcuity Inc. stock price move sharplyFree Elite Traders Group - Newser
How Celcuity Inc. stock performs during market volatilityBreakout Momentum Alerts - Newser
Why Celcuity Inc. stock attracts strong analyst attentionProven High Yield Signals - Newser
How To Trade (CELC) - news.stocktradersdaily.com
Celcuity Soars 17.16% on New Patent for Breast Cancer Drug - AInvest
Celcuity receives U.S. patent for gedatolisib dosing regimen - Investing.com
Celcuity Receives New Patent for Gedatolisib - MarketScreener
Celcuity receives U.S. patent for gedatolisib dosing regimen By Investing.com - Investing.com South Africa
Celcuity Announces Issuance of New Patent for Gedatolisib that Extends Patent Exclusivity into 2042 - The Manila Times
Celcuity, Inc. (NASDAQ:CELC) Receives $28.40 Average Target Price from Analysts - Defense World
Celcuity projects $2B revenue potential for gedatolisib in second-line breast cancer market - MSN
Celcuity(CELC) Shares Soar 4.70% on Phase 2 Trial Success - AInvest
Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention - PentictonNow
Learn to Evaluate (CELC) using the Charts - news.stocktradersdaily.com
Stifel Initiates Celcuity(CELC.US) With Buy Rating, Announces Target Price $30 - 富途牛牛
Celcuity (NASDAQ:CELC) Given Buy Rating at Needham & Company LLC - Defense World
Celcuity Announces Promising Phase 1 Gedatolisib Results - TipRanks
Celcuity reports positive early data for gedatolisib in cancer trials - Investing.com Australia
Rhumbline Advisers Has $427,000 Stock Position in Celcuity, Inc. (NASDAQ:CELC) - Defense World
Analysts Set Celcuity Inc. (NASDAQ:CELC) Price Target at $30.80 - Defense World
Wealth Enhancement Advisory Services LLC Grows Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Stocks in play: Roots Corp. - The Globe and Mail
(CELC) Trading Advice - news.stocktradersdaily.com
Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - Revista ADVFN
Cisco Powers AI-Ready Data Centers, From Hyperscale to Enterprise - The Globe and Mail
Millennium Management LLC Has $519,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Two Sigma Investments LP Has $679,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Nuveen Asset Management LLC Grows Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Ballard announces 1.5 MW fuel cell engine order for Sierra Northern Railway - The Globe and Mail
Citadel Advisors LLC Buys New Stake in HUHUTECH International Group Inc. (NASDAQ:HUHU) - Defense World
Two Sigma Advisers LP Decreases Stock Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Sold by BNP Paribas Financial Markets - Defense World
Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - ACCESS Newswire
BMO Lowers Fees on Asset Allocation ETFs to Deliver Greater Value to Investors - The Globe and Mail
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $258,000 Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Deutsche Bank AG Purchases 9,174 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Cetera Investment Advisers Trims Position in Franklin Limited Duration Income Trust (NYSEAMERICAN:FTF) - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World
BlackRock Floating Rate Income Strategies Fund, Inc. (NYSE:FRA) Shares Acquired by Cetera Investment Advisers - Defense World
Schwab U.S. REIT ETF (NYSEARCA:SCHH) Stock Holdings Raised by Bank of America Corp DE - Defense World
Citadel Advisors LLC Sells 24,240 Shares of Goldman Sachs Access Inflation Protected USD Bond ETF (BATS:GTIP) - Defense World
BNP Paribas Financial Markets Sells 19,586 Shares of NovaGold Resources Inc. (NYSEAMERICAN:NG) - Defense World
Bank of America Corp DE Has $3.77 Million Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
H-CYTE (OTCMKTS:HCYTD) Stock Price Down 49.5% – What’s Next? - Defense World
Celcuity at TD Cowen’s Oncology Summit: Exploring Gadotelisib’s Potential By Investing.com - Investing.com Canada
Celcuity at TD Cowen’s Oncology Summit: Exploring Gadotelisib’s Potential - Investing.com India
Tourmaline Oil (OTCMKTS:TRMLF) Stock Price Up 1.9% – What’s Next? - Defense World
AIB Group (OTCMKTS:AIBRF) Stock Price Up 0.3% – Here’s Why - Defense World
FIBRA Prologis (OTCMKTS:FBBPF) Stock Price Down 1.1% – Here’s Why - Defense World
Finanzdaten der Celcuity Inc-Aktie (CELC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):